Micronutrient Supplements in Inflammatory Bowel Disease

Disease-a-Month

Volumn 52, Issue 5, 2006, Pages 211-220

  Karp, Sean M ^a   Koch, Timothy R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALENDRONIC ACID; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; CYANOCOBALAMIN; DIMETHYL SULFOXIDE; ERGOCALCIFEROL; FERRIC HYDROXIDE SUCROSE; FERROUS SULFATE; FOLIC ACID; GLUTAMINE; GLUTATHIONE; IRON; MESALAZINE; OMEPRAZOLE; PHYTOMENADIONE; RETINOL; RISEDRONIC ACID; SALAZOSULFAPYRIDINE; SELENIUM; SUPEROXIDE DISMUTASE; TRACE ELEMENT; UNINDEXED DRUG; VITAMIN D; ZINC SULFATE;

ANEMIA; ARTICLE; CALCIUM ABSORPTION; CHEMOLUMINESCENCE; CHRONIC DIARRHEA; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; ENTERITIS; HEPATITIS; HUMAN; ILEITIS; IRON DEFICIENCY; MAGNESIUM DEFICIENCY; NONHUMAN; RETINOL DEFICIENCY; SELENIUM DEFICIENCY; STEATORRHEA; STOMACH PROTECTION; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; ZINC DEFICIENCY;

ANTIOXIDANTS; COMPLEMENTARY THERAPIES; DIET; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICRONUTRIENTS;

EID: 33745653133     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2006.05.008     Document Type: Article

References (30)

1. Hanauer S.B. Crohn's disease. step up or top down therapy. Best Pract Res Clin Gastroenterol 17 1 (2003) 131-137
2. Halliwell B., Zhao K., and Whiteman M. The gastrointestinal tract. a major site of antioxidant action?. Free Radic Res 33 (2000) 819-830
3. Siffledeen J.S., Fedorak R.N., Siminoski K., et al. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol 3 2 (2005) 122-132
4. Sharabi A., Cohen E., Sulkes J., et al. Replacement therapy for vitamin B12 deficiency. comparison between the sublingual and oral route. Br J Clin Pharmacol 56 6 (2003) 635-638
5. Schroder O., Mickisch O., Seidler U., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100 10 (2005) 2503-2509
6. Den Hond E., Hiele M., Peeters M., et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. J Parenter Enteral Nutr 23 1 (1999) 7-11
7. Wright J.P., Mee A.S., Parfitt A., et al. Vitamin A therapy in patients with Crohn's disease. Gastroenterology 88 (1985) 512-514
8. Miyachi Y., Yoshioka A., Imamura S., et al. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 28 2 (1987) 190-195
9. Ahnfelt-Ronne I., and Nielsen O.H. The anti-inflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 21 1-2 (1987) 191-194
10. Grisham M.B., and Miles A.M. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 47 10 (1994) 1897-1902
11. Simmonds N.J., Millar A.D., Blake D.R., et al. Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease. assessment in cell-free systems and inflamed human colorectal biopsies. Aliment Pharmacol Ther 13 (1999) 363-372
12. Jarnerot G., Strom M., Danielsson A., et al. Allopurinol in addition to 5-aminosalicyclic acid based drugs for the maintenance treatment of ulcerative colitis. Aliment Pharmacol Ther 14 (2000) 1159-1162
13. Salim A.S. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis. a new approach. J Lab Clin Med 119 6 (1992) 710-717
14. Hawkes N.D., Richardson C., Ch'Ng C.L., et al. Enteric-release glyceryl trinitrate in active Crohn's disease. a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 15 12 (2001) 1867-1873
15. Lapenna D., de Gioia S., Ciofani G., et al. Antioxidant properties of omeprazole. FEBS Lett 382 (1996) 189-192
16. 245. Gut 33 (1992) 617-621
17. Suzuki M., Mori M., Miura S., et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21 (1996) 727-731
18. Biswas K., Bandyopadhyay U., Chattopadhyay I., et al. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278 (2003) 10993-11001
19. Koch T.R., Yuan L.-X., Petro A., et al. Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion. Dig Dis Sci 47 (2002) 2486-2492
20. Koch T.R., Petro A., Darrabie M., et al. Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy. Dig Dis Sci 50 (2005) 86-93
21. Aghdassi E., Wendland B.E., Steinhart A.H., et al. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am J Gastroenterol 98 (2003) 348-353
22. Geerling B.J., Badart-Smook A., van Deursen C., et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission. effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6 2 (2000) 77-84
23. Niwa Y., Somiya K., Michelson A., et al. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disease. A preliminary study. Free Rad Res Commun 1 (1985) 137-153
24. Emerit J., Pelletier S., Tosoni-Verlignue D., et al. Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohns disease. Free Radic Biol Med 7 (1989) 145-149
25. Seidner D.L., Lashner B.A., Brzezinski A., et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis. a randomized, controlled trial. Clin Gastroenterol Hepatol 3 4 (2005) 358-369
26. Hilsden R.J., Scott C.M., and Verhoef M.J. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 93 (1998) 697-701
27. Rawsthorne P., Shanahan F., Cronin N.C., et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 94 (1999) 1298-1303
28. Kong S.C., Hurlstone D.P., Pocock C.Y., et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. Ali Tract. Clin Res 39 (2005) 138-141
29. Langmead L., Dawson C., Hawkins C., et al. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease. an in vitro study. Aliment Pharmacol Ther 16 2 (2002) 197-205
30. Langmead L., and Rampton D.S. Herbal treatment in gastrointestinal and liver disease. benefits and dangers. Aliment Pharmacol Ther 15 (2001) 1239-1252